PF-Atlas › Mechanisms › Selective PDE4B inhibitor — elevates cAMP, suppresses pro-inflammatory cytokines and fibroblast activation
Selective PDE4B inhibitor — elevates cAMP, suppresses pro-inflammatory cytokines and fibroblast activation in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Selective PDE4B inhibitor — elevates cAMP, suppresses pro-inflammatory cytokines and fibroblast activation is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting Selective PDE4B inhibitor — elevates cAMP, suppresses pro-inflammatory cytokines and fibroblast activation
Therapies
Medical disclaimer. This is a research summary, not medical advice.